PMS71 Cost-Effectiveness of Alendronate Therapy for Osteopenic Postmenopausal Women in Japan

Value in Health - United Kingdom
doi 10.1016/j.jval.2012.03.260
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Cost-Effectiveness of Teriparatide Compared With Alendronate and Risedronate for the Treatment of Postmenopausal Osteoporosis Patients in Iran

Medical Journal of the Islamic Republic of Iran
Medicine
2017English

Serum Osteocalcin Levels in Postmenopausal Osteoporotic Women Receiving Alendronate

Rheumatology Research
2018English

Spectroscopic Markers of Bone Quality in Alendronate-Treated Postmenopausal Women

Osteoporosis International
MedicineEndocrinologyMetabolismDiabetes
2008English

In Vivo Evaluation of the Presence of Bone Marrow in Cortical Porosity in Postmenopausal Osteopenic Women

Annals of Biomedical Engineering
Biomedical Engineering
2009English

Single and 7-Day Multiple Dose Studies of Alendronate (MK-217) in Postmenopausal Women.

Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
1995English

Impact of Generic Alendronate Cost on the Cost-Effectiveness of Osteoporosis Screening and Treatment

PLoS ONE
Multidisciplinary
2012English

Cost-Effectiveness of Percutaneous Coronary Intervention Compared With Medical Therapy for Ischemic Heart Disease in Japan

Circulation Journal
MedicineCardiovascular MedicineCardiology
2019English

Cost-Effectiveness of Antiretroviral Therapy for Prevention

Current HIV Research
VirologyInfectious Diseases
2011English

Hormone Therapy for Primary Prevention of Chronic Conditions in Postmenopausal Women

JAMA - Journal of the American Medical Association
Medicine
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy